Inventor · disambiguated record
Yann Godfrin
Also filed as: GODFRIN YANN
17 granted patents·15 pending applications·204 citations·filing 2004–2022
94Inventor score
Files withERYTECH PHARMA17GODFRIN YANN5AXOLTIS PHARMA4BOURGEAUX VANESSA3BECTON DICKINSON INFUSION THERAPY SYSTEMS INC1
Top patents by PatentIndex Score
32 records- 0194US9950049B2Composition and therapeutic anti-tumour vaccineERYTECH PHARMA·Filed 2016·Granted Apr 24, 2018·26 cites·22 claims
- 0293US9364504B2Compostition and therapeutic anti-tumour vaccineGODFRIN YANN·Filed 2008·Granted Jun 14, 2016·38 cites·42 claims
- 0392US8852880B2Test for predicting neutralization of asparaginase activityGODFRIN YANN·Filed 2009·Granted Oct 7, 2014·15 cites·17 claims
- 0492US8617840B2Lysis/resealing process and device for incorporating an active ingredient, in particular asparaginase or inositol hexaphosphate, in erythrocytesGODFRIN YANN·Filed 2005·Granted Dec 31, 2013·26 cites·26 claims
- 0590US10780151B2Composition and therapeutic anti-tumour vaccineERYTECH PHARMA·Filed 2018·Granted Sep 22, 2020·4 cites·18 claims
- 0690US10046009B2Method of treatment using a pharmaceutical composition comprising erythrocytes encapsulating a PLP-dependent enzyme and its cofactorERYTECH PHARMA·Filed 2015·Granted Aug 14, 2018·14 cites·15 claims
- 0786US9125876B2Erythrocytes containing arginine deiminaseGODFRIN YANN·Filed 2006·Granted Sep 8, 2015·16 cites·8 claims
- 0883US8974802B2Medicament for the treatment of cancer of the pancreasDUFOUR EMMANUELLE-CÉCILE·Filed 2008·Granted Mar 10, 2015·17 cites·12 claims
- 0980US10273444B2Lysis/resealing process and device for incorporating an active ingredient, in particular asparaginase or inositol hexaphosphate, in erythrocytesERYTECH PHARMA·Filed 2013·Granted Apr 30, 2019·4 cites·19 claims
- 1080US8507237B2Device and method for concentrating and detecting pathogenic microbes from blood products and/or their derivativesHERMET JEAN-PIERRE·Filed 2004·Granted Aug 13, 2013·30 cites·23 claims
- 1179US11141468B2Method of treating a mammal, including human, against cancer using methionine and asparagine depletionERYTECH PHARMA·Filed 2017·Granted Oct 12, 2021·3 cites·9 claims
- 1278US10780126B2Pharmaceutical kit comprising erythrocytes encapsulating a PLP-dependent enzyme and, a non-phosphate PLP precursorERYTECH PHARMA·Filed 2018·Granted Sep 22, 2020·2 cites·14 claims
- 1378US9580739B2Test for predicting neutralization of asparaginase activityERYTECH PHARMA·Filed 2014·Granted Feb 28, 2017·3 cites·27 claims
- 1477US9968663B2Erythrocytes containing arginine deiminaseERYTECH PHARMA·Filed 2015·Granted May 15, 2018·3 cites·7 claims
- 1573US10286008B2Method for stabilising suspensions of red blood cells encapsulating an active ingredientERYTECH PHARMA·Filed 2014·Granted May 14, 2019·3 cites·16 claims
- 1667US11458170B2Pharmaceutical composition comprising erythrocytes encapsulating a PLP-dependent enzyme and, a non-phosphate PLP precursorERYTECH PHARMA·Filed 2020·Granted Oct 4, 2022·0 cites·19 claims
- 1766US2021077602A1Composition and therapeutic anti-tumour vaccineERYTECH PHARMA·Filed 2020·Application pending·0 cites
- 1860US2021268082A1METHOD OF INDUCING IMMUNE TOLERANCE BY ADMINISTERING ACTIVE PRINCIPLE-LOADING RBC'sERYTECH PHARMA·Filed 2021·Application pending·0 cites
- 1960US2025152660A1SCO-spondin-derived polypeptides for treating biological barriers dysfunctionAXOLTIS PHARMA·Filed 2022·Application pending·0 cites
- 2059US2011014171A1Formulation and Method for the Prevention and Treatment of Bone Metastases or Other Bone DiseasesBOURGEAUX VANESSA·Filed 2009·Application pending·0 cites
- 2158US2025177481A1SCO-spondin-derived polypeptides for enhancing synaptic transmissionAXOLTIS PHARMA·Filed 2022·Application pending·0 cites
- 2256US2022040272A1Method of treating a mammal, including human, against cancer using methionine and asparagine depletionERYTECH PHARMA·Filed 2021·Application pending·0 cites
- 2355US2014363413A1Formulation and method for the prevention and treatment of bone metastases or other bone diseasesERYTECH PHARMA·Filed 2014·Application pending·0 cites
- 2454US2010316620A1Formulation and Method for the Prevention and Treatment of Skeletal Manifestation of Gaucher's DiseaseBOURGEAUX VANESSA·Filed 2008·Application pending·0 cites
- 2553US2014010795A1Formulation and method for the prevention and treatment of bone metastases or other bone diseasesERYTECH PHARMA·Filed 2013·Application pending·0 cites
- 2650US2015086521A1Medicament for the Treatment of Acute Myeloid Leukemia (AML)ERYTECH PHARMA·Filed 2013·Application pending·0 cites
- 2749US8822211B2Device and method for concentrating and detecting pathogenic microbes from blood products and/or their derivativesBECTON DICKINSON INFUSION THERAPY SYSTEMS INC·Filed 2013·Granted Sep 2, 2014·0 cites·8 claims
- 2847US2016120956A1Composition of erythrocytes encapsulating phenylalanine hydroxylase and therapeutic use thereofERYTECH PHARMA·Filed 2014·Application pending·0 cites
- 2943US2023212225A1Peptide compostions and methods for treating tauopathiesAXOLTIS PHARMA·Filed 2020·Application pending·0 cites
- 3042US2023073781A1Systemic administration of peptides for the treatment of spinal cord injury and/or for remyelinationAXOLTIS PHARMA·Filed 2020·Application pending·0 cites
- 3142US2012207745A1Composition to Induce Specific Immune ToleranceGODFRIN YANN·Filed 2010·Application pending·0 cites
- 3236US2012129210A1Method for Assaying Inositol Hexaphosphate (IHP)BOURGEAUX VANESSA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yann Godfrin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →